Authors' reply to the comment "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa". uri icon

Overview

publication date

  • November 27, 2020

Research

keywords

  • Hidradenitis Suppurativa

Identity

Scopus Document Identifier

  • 85101689945

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2020.11.041

PubMed ID

  • 33253838

Additional Document Info

volume

  • 84

issue

  • 4